No abstract available
Keywords:
Cervical cancer; Checkpoint blockade; Endometrial cancer; Immunotherapy; Pembrolizumab; Toxicity.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Humans
-
Immunotherapy* / adverse effects
-
Programmed Cell Death 1 Receptor*
Substances
-
Programmed Cell Death 1 Receptor